# A Study To Evaluate The Safety And Effects On The Body Of An Investigational Drug Using An Endotoxin-Induced Inflammatory Response Model

> **NCT01965600** · PHASE1 · TERMINATED · sponsor: **Pfizer** · enrollment: 23 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-06282999
- **DRUG:** Placebo
- **OTHER:** LPS
- **DRUG:** PF-06282999
- **DRUG:** Placebo
- **OTHER:** LPS

## Key facts

- **NCT ID:** NCT01965600
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-03
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2016-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01965600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01965600, "A Study To Evaluate The Safety And Effects On The Body Of An Investigational Drug Using An Endotoxin-Induced Inflammatory Response Model". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01965600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*